Labcorp Holdings Inc. (LH) stock
LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3016% above fair value
$368.24−4.22 (-1.13%)
Close on Nov 17, 2026Market cap $29.90BP/E 30.2Yield 0.78%
Labcorp revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Labcorp's revenue for the twelve months ending Sep 30, 2026 was $14.59B, up 6.0% year over year. For fiscal 2025 it was $13.95B, up 7.2% from the year before. Over ten years it grew 4.9% a year on average. The highest annual figure on record is $13.98B in fiscal 2020.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.95B | +7.2% |
| FY2024 | Dec 31, 2024 | $13.01B | +7.0% |
| FY2023 | Dec 31, 2023 | $12.16B | +2.5% |
| FY2022 | Dec 31, 2022 | $11.86B | -9.7% |
| FY2021 | Dec 31, 2021 | $13.14B | -6.0% |
| FY2020 | Dec 31, 2020 | $13.98B | +21.0% |
| FY2019 | Dec 31, 2019 | $11.55B | +2.0% |
| FY2018 | Dec 31, 2018 | $11.33B | +9.9% |
| FY2017 | Dec 31, 2017 | $10.31B | +7.9% |
| FY2016 | Dec 31, 2016 | $9.55B | +10.1% |
| FY2015 | Dec 31, 2015 | $8.68B | +44.4% |
| FY2014 | Dec 31, 2014 | $6.01B | +3.5% |
| FY2013 | Dec 31, 2013 | $5.81B | +2.4% |
| FY2012 | Dec 31, 2012 | $5.67B | +2.3% |
| FY2011 | Dec 31, 2011 | $5.54B | +10.8% |
| FY2010 | Dec 31, 2010 | $5.00B | +6.6% |
| FY2009 | Dec 31, 2009 | $4.69B | +4.2% |
| FY2008 | Dec 31, 2008 | $4.51B | +10.7% |
| FY2007 | Dec 31, 2007 | $4.07B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.81B | +6.9% |
| Q2 FY2026 | Jun 30, 2026 | $3.73B | +5.8% |
| Q1 FY2026 | Mar 31, 2026 | $3.54B | +5.8% |
| Q4 FY2025 | Dec 31, 2025 | $3.52B | +5.6% |
| Q3 FY2025 | Sep 30, 2025 | $3.56B | +8.6% |
| Q2 FY2025 | Jun 30, 2025 | $3.53B | +9.5% |
| Q1 FY2025 | Mar 31, 2025 | $3.35B | +5.3% |
| Q4 FY2024 | Dec 31, 2024 | $3.33B | +9.8% |
| Q3 FY2024 | Sep 30, 2024 | $3.28B | +7.4% |
| Q2 FY2024 | Jun 30, 2024 | $3.22B | +6.2% |
| Q1 FY2024 | Mar 31, 2024 | $3.18B | +4.6% |
| Q4 FY2023 | Dec 31, 2023 | $3.03B | +3.5% |
| Q3 FY2023 | Sep 30, 2023 | $3.06B | +6.6% |
| Q2 FY2023 | Jun 30, 2023 | $3.03B | +3.8% |
| Q1 FY2023 | Mar 31, 2023 | $3.04B | -22.1% |
| Q4 FY2022 | Dec 31, 2022 | $2.93B | +173.5% |
| Q3 FY2022 | Sep 30, 2022 | $2.87B | -29.4% |
| Q2 FY2022 | Jun 30, 2022 | $2.92B | -23.9% |
| Q1 FY2022 | Mar 31, 2022 | $3.90B | -6.3% |
| Q4 FY2021 | Dec 31, 2021 | $1.07B | -76.1% |
| Q3 FY2021 | Sep 30, 2021 | $4.06B | +4.3% |
| Q2 FY2021 | Jun 30, 2021 | $3.84B | +38.7% |
| Q1 FY2021 | Mar 31, 2021 | $4.16B | +47.4% |
| Q4 FY2020 | Dec 31, 2020 | $4.49B | +52.0% |
| Q3 FY2020 | Sep 30, 2020 | $3.90B | +33.0% |
| Q2 FY2020 | Jun 30, 2020 | $2.77B | -3.9% |
| Q1 FY2020 | Mar 31, 2020 | $2.82B | +1.2% |
| Q4 FY2019 | Dec 31, 2019 | $2.95B | +6.0% |
| Q3 FY2019 | Sep 30, 2019 | $2.93B | +3.4% |
| Q2 FY2019 | Jun 30, 2019 | $2.88B | +0.5% |
| Q1 FY2019 | Mar 31, 2019 | $2.79B | -2.0% |
| Q4 FY2018 | Dec 31, 2018 | $2.79B | +1.6% |
| Q3 FY2018 | Sep 30, 2018 | $2.83B | +8.0% |
| Q2 FY2018 | Jun 30, 2018 | $2.87B | +13.4% |
| Q1 FY2018 | Mar 31, 2018 | $2.85B | +18.0% |
| Q4 FY2017 | Dec 31, 2017 | $2.74B | +15.0% |
| Q3 FY2017 | Sep 30, 2017 | $2.62B | – |
| Q2 FY2017 | Jun 30, 2017 | $2.53B | – |
| Q1 FY2017 | Mar 31, 2017 | $2.41B | – |
| Q4 FY2016 | Dec 31, 2016 | $2.39B | – |
See a number that looks wrong?